-
Kroger to launch its 1st personalized medicine trial
Kroger Health, the national grocery chain's healthcare division, will set up clinical trial sites for research on colorectal cancer gut and immune health with the aim of developing personalized medicines. -
Pharma's 15 biggest lobbyists
Thirty-two lobbying groups representing the pharmaceutical industry spent more than $2 million in 2022, Politico reported Jan. 24. -
'Ozempic face': A rare result of popular weight-loss drugs
Dramatic weight-loss results from drugs such as Ozempic, Wegovy and Mounjaro are joining a less-desired outcome: a deflation in the face, The New York Times reported Jan. 24. -
Phoenix Children's to create specialty pharmacy program
Phoenix Children's, a two-hospital pediatric system, partnered with Shields Health Solutions Jan. 24 to help design and implement its specialty pharmacy program. -
Meet the 3 PBMs partnered with Mark Cuban's pharmacy
After Mark Cuban Cost Plus Drug Co. rerouted plans and partnered with a pharmacy benefit manager in September, the 1-year-old online pharmacy has grabbed two similar deals. -
Amazon rolls out RxPass prescription service for $5 per month
Amazon Pharmacy rolled out RxPass, a $5 per month medication prescription service, on Jan. 24. -
CVS refreshes executive team
CVS Health tapped a new chief policy officer and leaders of its pharmacy services business and consumer business. -
FDA OKs hospitals to compound ibuprofen amid drug shortage
As drugmakers report high demand and waning supply of pediatric fever-reducers, the FDA posted an immediately-in-effect guidance Jan. 20 to help boost access to ibuprofen oral suspension products. -
Optum Rx's new tool secures lowest prescription drug prices, company says
UnitedHealth Group's pharmacy services company launched a new tool Jan. 23 for its members to compare generic drugs' direct-to-consumer prices. -
Trailblazing pharmacist Dr. Charles Champion dies at 92
Charles Champion, PharmD, the first Black pharmacist to work at a Memphis, Tenn., hospital, died Jan. 21 at 92, ABC24 reported Jan. 21. -
Civica chooses exclusive distributor
Civica Rx, a nonprofit drugmaker formed four years ago by health systems, picked AmerisourceBergen as its exclusive distribution partner. -
Feds to pharmacies: Give unused N95s to healthcare workers
The federal government asked pharmacies to scrounge up the N95 respirators they received and offer them to healthcare providers and health centers. -
Biden directs HHS to protect abortion pill access
President Joe Biden on Jan. 22 issued a memorandum directing HHS to "consider new guidance" to protect legal access to abortion pills in the U.S. -
FTC asks for Shkreli to be held in contempt
The infamous "Pharma Bro" Martin Shkreli should be held in contempt for opening another drug company, the Federal Trade Commission urged a federal judge Jan. 20. -
NYU Langone Health exits diabetes vaccine trial
Researchers from New York City-based NYU Langone Health departed from a trial investigating a tuberculosis vaccine's potential as a pediatric Type 1 diabetes vaccine, The New York Times reported Jan. 20. -
FDA denies Eli Lilly's Alzheimer's drug an accelerated approval
The FDA asked Eli Lilly to provide more data on its early-stage Alzheimer's drug, donanemab, before it can decide to add it to its accelerated approval program, the drugmaker said Jan. 19. -
Ohio hospital to build specialty pharmacy program
Knox Community Hospital partnered with pharmacy solutions company CarepathRx on Jan. 19 to help create the Mount Vernon, Ohio-based hospital's specialty pharmacy program. -
Rite Aid to dispense abortion pills
Rite Aid joined CVS and Walgreens in planning to dispense mifepristone, one of the two pills used for medication abortion, the retail pharmacy chain told Becker's. -
Pharmacist-led protocols could improve patient sedation outcomes
Researchers found patients have worse outcomes when put under early deep sedation in the intensive care unit, but pharmacist-led protocols could help. -
3 systems' leaders join 340B Health's board of directors
Executives from three health systems have joined the board of directors for 340B Health, an organization that represents the hundreds of hospitals part of a federal drug pricing program.
Page 17 of 50